• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过诱导表达HIV-1蛋白酶多聚体对人类免疫缺陷病毒1型(HIV-1)复制的强效抑制

Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers.

作者信息

Arrigo S J, Huffman K

机构信息

Department of Microbiology and Immunology, Medical University of South Carolina, Charleston 29425-2230, USA.

出版信息

J Virol. 1995 Oct;69(10):5988-94. doi: 10.1128/JVI.69.10.5988-5994.1995.

DOI:10.1128/JVI.69.10.5988-5994.1995
PMID:7666503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC189494/
Abstract

Constructs were generated in which expression of human immunodeficiency virus type 1 (HIV-1) protease (PR) was placed under control of the HIV-1 long terminal repeat, thus requiring the HIV-1 Tat protein for expression of PR. The activity of PR was assessed by cotransfection with a construct producing a Gag substrate. Expression of PR as an intramolecular multimer resulted in a large increase in PR activity in comparison with the level obtained with the expression of PR as a monomer. A cytotoxic effect of PR expression was also exhibited by the constructs expressing PR multimers. CD4+ T-cell lines were generated with a construct producing PR as a linked tetramer and screened for PR activity and inducibility. The replication of HIV-1 in these cell lines was several orders of magnitude reduced in comparison with that in cell lines not expressing PR. Infection in these cell lines could be detected early after infection but disappeared over time. Infection of the PR-expressing cell lines could be increased several orders of magnitude by the addition of a specific inhibitor of PR, U75875 (Upjohn), after infection of the cells, demonstrating that the potent inhibition of HIV-1 replication in these cells was directly due to the expression of PR.

摘要

构建了一些载体,其中人类免疫缺陷病毒1型(HIV-1)蛋白酶(PR)的表达置于HIV-1长末端重复序列的控制之下,因此PR的表达需要HIV-1反式激活因子(Tat)蛋白。通过与产生Gag底物的载体共转染来评估PR的活性。与以单体形式表达PR相比,以分子内多聚体形式表达PR导致PR活性大幅增加。表达PR多聚体的载体也表现出PR表达的细胞毒性作用。用产生作为连接四聚体的PR的载体生成CD4 + T细胞系,并筛选PR活性和诱导性。与未表达PR的细胞系相比,HIV-1在这些细胞系中的复制降低了几个数量级。在这些细胞系中感染可在感染后早期检测到,但随时间消失。在细胞感染后添加PR的特异性抑制剂U75875(Upjohn)可使表达PR的细胞系中的感染增加几个数量级,这表明这些细胞中HIV-1复制的有效抑制直接归因于PR的表达。

相似文献

1
Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers.通过诱导表达HIV-1蛋白酶多聚体对人类免疫缺陷病毒1型(HIV-1)复制的强效抑制
J Virol. 1995 Oct;69(10):5988-94. doi: 10.1128/JVI.69.10.5988-5994.1995.
2
Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity.人类免疫缺陷病毒1型蛋白酶的过表达会增加Gag的细胞内切割并降低病毒感染性。
Virology. 1995 Feb 1;206(2):854-65. doi: 10.1006/viro.1995.1008.
3
Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.Tat-人类免疫缺陷病毒的感染与复制:原代及长期人类淋巴细胞中LTR和tat突变的遗传分析
Virology. 1995 Aug 1;211(1):157-69. doi: 10.1006/viro.1995.1388.
4
Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.通过在长末端重复序列中含有1型人类嗜T淋巴细胞病毒(HTLV-1)tax反应元件的嵌合型人类免疫缺陷病毒对HTLV-1感染细胞进行选择性感染。
J Virol. 1995 Nov;69(11):7216-25. doi: 10.1128/JVI.69.11.7216-7225.1995.
5
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.通过调控表达聚合型Tat激活反应RNA诱饵抑制人类免疫缺陷病毒1型复制,作为艾滋病基因治疗的一种策略。
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8000-4. doi: 10.1073/pnas.90.17.8000.
6
Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.IκBα的反式显性突变体可阻断Tat-肿瘤坏死因子对人免疫缺陷病毒1型基因表达和病毒增殖的协同激活作用。
J Virol. 1996 Sep;70(9):5777-85. doi: 10.1128/JVI.70.9.5777-5785.1996.
7
Intrinsic activity of human immunodeficiency virus type 1 protease heterologous fusion proteins in mammalian cells.1型人类免疫缺陷病毒蛋白酶异源融合蛋白在哺乳动物细胞中的内在活性。
DNA Cell Biol. 1995 Jan;14(1):15-23. doi: 10.1089/dna.1995.14.15.
8
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.p6Gag是从表达蛋白酶的全长1型人类免疫缺陷病毒分子克隆产生病毒颗粒所必需的。
J Virol. 1995 Nov;69(11):6810-8. doi: 10.1128/JVI.69.11.6810-6818.1995.
9
Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.1型人类免疫缺陷病毒与爱泼斯坦-巴尔病毒在T淋巴母细胞系中的协同作用。
AIDS Res Hum Retroviruses. 1997 Jan 20;13(2):161-71. doi: 10.1089/aid.1997.13.161.
10
Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).人类免疫缺陷病毒1型Tat蛋白在体外的转录激活:与一种或多种共激活因子特异性相互作用的证据。
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9357-61. doi: 10.1073/pnas.91.20.9357.

引用本文的文献

1
Mechanism and Kinetics of HIV-1 Protease Activation.HIV-1蛋白酶激活的机制与动力学
Viruses. 2024 Nov 25;16(12):1826. doi: 10.3390/v16121826.
2
HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.HIV-1 逆转录酶稳定性与 Gag 切割效率相关:逆转录酶相互作用对调节蛋白酶激活的意义。
J Virol. 2023 Sep 28;97(9):e0094823. doi: 10.1128/jvi.00948-23. Epub 2023 Sep 6.
3
Neutral sphingomyelinase 2 is required for HIV-1 maturation.中性鞘磷脂酶 2 是 HIV-1 成熟所必需的。
Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2219475120. doi: 10.1073/pnas.2219475120. Epub 2023 Jul 5.
4
The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release.HIV-1 病毒蛋白酶在组装和出芽过程中被激活,然后才释放病毒颗粒。
J Virol. 2022 May 11;96(9):e0219821. doi: 10.1128/jvi.02198-21. Epub 2022 Apr 19.
5
HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.HIV-1 突变体组装、加工和感染性表达与 gag 无关,独立于 pol。
Viruses. 2020 Jan 2;12(1):54. doi: 10.3390/v12010054.
6
C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.C 端 HIV-1 移框 p6* 四肽可阻断因亮氨酸拉链取代缺失的 p6* 结构域而导致的 Gag 切割增强。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.00103-17. Print 2017 May 15.
7
Gag-Pol Transframe Domain p6* Is Essential for HIV-1 Protease-Mediated Virus Maturation.Gag-Pol跨框结构域p6*对于HIV-1蛋白酶介导的病毒成熟至关重要。
PLoS One. 2015 Jun 1;10(6):e0127974. doi: 10.1371/journal.pone.0127974. eCollection 2015.
8
HIV-1 matrix domain removal ameliorates virus assembly and processing defects incurred by positive nucleocapsid charge elimination.HIV-1基质结构域的去除改善了因正核衣壳电荷消除而导致的病毒组装和加工缺陷。
FEBS Open Bio. 2015 Apr 9;5:283-91. doi: 10.1016/j.fob.2015.04.003. eCollection 2015.
9
Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.HIV-1 蛋白酶羧基末端亮氨酸拉链模体的定位显著降低了病毒粒子的产生。
PLoS One. 2012;7(3):e32845. doi: 10.1371/journal.pone.0032845. Epub 2012 Mar 1.
10
A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.HIV-1 逆转录酶中的单个氨基酸取代可显著降低病毒粒子的释放。
J Virol. 2010 Jan;84(2):976-82. doi: 10.1128/JVI.01532-09. Epub 2009 Nov 4.

本文引用的文献

1
Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.1型人类免疫缺陷病毒蛋白酶对人和小鼠细胞骨架及肌节蛋白的切割作用。包括肌动蛋白、结蛋白、肌球蛋白和原肌球蛋白。
Am J Pathol. 1993 Jan;142(1):221-30.
2
Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.在稳定表达HIV-1 gag和env基因产物且有或无活性HIV蛋白酶的哺乳动物细胞系中分析蛋白质表达和病毒样颗粒形成。
Virology. 1993 Feb;192(2):605-17. doi: 10.1006/viro.1993.1077.
3
Gene therapy: a bold direction for HIV-1 treatment.基因疗法:HIV-1治疗的一个大胆方向。
AIDS Res Hum Retroviruses. 1993 May;9(5):483-7. doi: 10.1089/aid.1993.9.483.
4
Intrinsic activity of human immunodeficiency virus type 1 protease heterologous fusion proteins in mammalian cells.1型人类免疫缺陷病毒蛋白酶异源融合蛋白在哺乳动物细胞中的内在活性。
DNA Cell Biol. 1995 Jan;14(1):15-23. doi: 10.1089/dna.1995.14.15.
5
Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.HIV-1 gag-pol多聚蛋白的过表达导致HIV-1蛋白酶在细胞内激活,并抑制病毒样颗粒的组装和出芽。
Virology. 1993 Apr;193(2):661-71. doi: 10.1006/viro.1993.1174.
6
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
7
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.人类嗜T淋巴细胞病毒III型(HTLV-III)的表达和产生涉及病毒RNA剪接和翻译水平的复杂调控。
Cell. 1986 Sep 12;46(6):807-17. doi: 10.1016/0092-8674(86)90062-0.
8
Active human immunodeficiency virus protease is required for viral infectivity.活跃的人类免疫缺陷病毒蛋白酶是病毒感染性所必需的。
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90. doi: 10.1073/pnas.85.13.4686.
9
HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.HIV-1蛋白酶对肽段切割的特异性足以对gag和pol多聚蛋白进行加工处理。
Biochem Biophys Res Commun. 1988 Oct 14;156(1):297-303. doi: 10.1016/s0006-291x(88)80839-8.
10
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.人嗜T细胞病毒III型(HTLV-III/LAV)长末端重复序列中顺式作用调节序列的定位
Cell. 1985 Jul;41(3):813-23. doi: 10.1016/s0092-8674(85)80062-3.